Vis enkel innførsel

dc.contributor.authorAusen, Kjersti
dc.contributor.authorHagen, Anne Irene
dc.contributor.authorSæther Østbyhaug, Heidi
dc.contributor.authorOlafsson, Sverrir
dc.contributor.authorKvalsund, Berit
dc.contributor.authorSpigset, Olav
dc.contributor.authorPleym, Hilde
dc.date.accessioned2020-02-20T09:16:23Z
dc.date.available2020-02-20T09:16:23Z
dc.date.created2020-01-04T19:14:00Z
dc.date.issued2019
dc.identifier.issn2474-9842
dc.identifier.urihttp://hdl.handle.net/11250/2642773
dc.description.abstractBackground: Topical administration of tranexamic acid (TXA) may be an alternative to intravenous administration to reduce bleeding with a lower risk of systemic adverse events. The aim of this study was to investigate whether moistening a surgical wound with TXA before closure, leaving a thin film of drug only, would reduce postoperative bleeding. Methods: This was a two‐centre, stratified, parallel‐group, placebo‐controlled, double‐blind RCT. Patients undergoing mastectomy with or without axillary lymph node clearance were randomized 1 : 1 to moistening of wound surface before closure with either 25 mg/ml TXA or 0·9 per cent sodium chloride (placebo). The primary endpoint was postoperative bleeding as measured by drain production in the first 24 h. Secondary endpoints were early haematoma, total drain production, postoperative complications and late aspirations of seroma within 3 months. Results: Between 1 January 2016 and 31 August 2018, 208 patients were randomized. Two patients were converted to a different surgical procedure at surgery, and four did not receive the intervention owing to technical error. Thus, 202 patients were included in the study (101 in the TXA and 101 in the placebo group). TXA reduced mean drain production at 24 h (110 versus 144 ml; mean difference 34 (95 per cent c.i. 8 to 60) ml, P = 0·011). One patient in the TXA group had early haematoma compared with seven in the placebo group (odds ratio (OR) 0·13 (95 per cent c.i. 0·02 to 1·07); P = 0·057). There was no significant difference in postoperative complications between TXA and placebo (13 versus 10; OR 1·11 (0·45 to 2·73), P = 0·824) or need for late seroma aspirations (79 versus 67 per cent; OR 1·83 (0·91 to 3·68), P = 0·089). Conclusion Moistening the wound with TXA 25 mg/ml before closure reduces postoperative bleeding within the first 24 h in patients undergoing mastectomy. Registration number: NCT02627560 (https://clinicaltrials.gov).nb_NO
dc.language.isoengnb_NO
dc.publisherWileynb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleTopical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trialnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.journalBJS Opennb_NO
dc.identifier.doi10.1002/bjs5.50248
dc.identifier.cristin1766291
dc.description.localcode© 2019 The Authors.BJS Openpublished by John Wiley & Sons Ltd on behalf of BJS Society LtdBJS OpenThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction inany medium, provided the original work is properly cited and is not used for commercial purposesnb_NO
cristin.unitcode194,65,25,0
cristin.unitcode1920,2,0,0
cristin.unitcode194,65,15,0
cristin.unitcode1920,14,0,0
cristin.unitcode1920,28,0,0
cristin.unitnameInstitutt for sirkulasjon og bildediagnostikk
cristin.unitnameKirurgisk klinikk
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.unitnameLaboratoriemedisinsk klinikk
cristin.unitnameKlinikk for anestesi og intensivmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal